Clinical Trial Update: Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pharmacokinetics and safety of bupivacaine HCl spinal block and EXPAREL local infiltration in total knee arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)
• bupivacaine HCl spinal block (bupivacaine hydrochloride)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2016-06-28